Congress Trades
Latest disclosures
| Chamber | Transaction Date | Member | Owner | Asset | Action | Amount | Ticker ▼ | Δ Since Trade |
|---|---|---|---|---|---|---|---|---|
| Senate | Feb. 20, 2020 | Kelly Loeffler | Spouse | AbbVie Inc. | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +141.95% |
| Senate | Jul. 9, 2020 | Thomas R. Carper | Spouse | AbbVie Inc. | SALE (PARTIAL) | $1,001 - $15,000 | ABBV | ▲ +132.79% |
| Senate | Jul. 15, 2019 | David Perdue | Joint | AbbVie Inc. | SALE (PARTIAL) | $15,001 - $50,000 | ABBV | ▲ +224.45% |
| Senate | Mar. 24, 2020 | Thomas R. Carper | Spouse | AbbVie Inc. | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +237.81% |
| Senate | Jan. 7, 2016 | David Perdue | Joint | AbbVie Inc. | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +298.51% |
| House | Jul. 2, 2024 | Kathy Manning | Spouse | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +37.38% |
| House | Jun. 17, 2025 | Lisa McClain | Spouse | AbbVie Inc | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +22.92% |
| House | May. 22, 2025 | Josh Gottheimer | Joint | AbbVie Inc | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +24.90% |
| House | Apr. 1, 2025 | Josh Gottheimer | Joint | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +10.53% |
| House | Apr. 17, 2025 | Josh Gottheimer | Joint | AbbVie Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +31.79% |
| House | Apr. 3, 2025 | Josh Gottheimer | Joint | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +13.07% |
| House | Apr. 17, 2025 | Jefferson Shreve | AbbVie Inc | SALE | $50,001 - $100,000 | ABBV | ▲ +31.79% | |
| House | Nov. 20, 2024 | Marjorie Taylor Greene | AbbVie Inc | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +35.90% | |
| House | Apr. 3, 2025 | Dwight Evans | AbbVie Inc | SALE | $1,001 - $15,000 | ABBV | ▲ +13.07% | |
| House | Feb. 24, 2025 | Jefferson Shreve | AbbVie Inc | PURCHASE | $50,001 - $100,000 | ABBV | ▲ +11.72% | |
| House | Aug. 4, 2025 | Marjorie Taylor Greene | AbbVie Inc | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +15.62% | |
| House | Jan. 15, 2025 | Jared Moskowitz | AbbVie Inc (2) | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +33.06% | |
| House | Dec. 6, 2024 | Virginia Foxx | AbbVie Inc | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +29.40% | |
| Senate | Aug. 11, 2025 | John Boozman | Joint | AbbVie Inc | SALE | $1,001 - $15,000 | ABBV | ▲ +14.74% |
| Senate | Aug. 22, 2025 | John Boozman | Joint | AbbVie Inc | SALE | $1,001 - $15,000 | ABBV | ▲ +8.26% |
| House | Oct. 14, 2024 | Ro Khanna | AbbVie Inc | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +16.53% | |
| House | May. 15, 2025 | Rob Bresnahan | AbbVie Inc | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +25.49% | |
| House | Sep. 4, 2024 | John James | AbbVie Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +15.73% | |
| House | Nov. 10, 2023 | John James | AbbVie Inc. Common Stock | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +64.51% | |
| House | Apr. 8, 2025 | Rob Bresnahan | AbbVie Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +29.78% | |
| House | Sep. 26, 2024 | Ritchie Torres | AbbVie Inc | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +18.81% | |
| House | Feb. 25, 2025 | Rob Bresnahan | AbbVie Inc | PURCHASE | $1,001 - $15,000 | ABBV | ▲ +11.68% | |
| Senate | Apr. 14, 2020 | David Perdue | Joint | AbbVie Inc. | SALE (FULL) | $15,001 - $50,000 | ABBV | ▲ +177.60% |
| Senate | Aug. 21, 2020 | Jerry Moran | Self | AbbVie Inc. | SALE (FULL) | $1,001 - $15,000 | ABBV | ▲ +140.34% |
| Senate | Apr. 14, 2020 | David Perdue | Joint | AbbVie Inc. | SALE (FULL) | $15,001 - $50,000 | ABBV | ▲ +177.60% |
Last updated: Oct 24, 23:03